High Neuro Drug Costs Exclude Most From Cutting-Edge Tx
Because of high out-of-pocket costs of new-to-market neurologic drugs that are of similar benefit as older agents, only a small percentage of patients with neurologic disorders have access to these cutting-edge medications, new research shows. “Our study of people with neurologic conditions found fewer than 20% were being treated with new medications,” study author Brian … Read more